drugset / Trial / NCT01313286

A Study to Compare Two Forms of LY2608204 in Healthy People

NCT01313286

Phase 1 Completed 16 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare 2 formulations of the study drug (LY2608204) in terms of how much gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected.

Timeline

Start
2011-03
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject LY2608204 Small molecule 80 mg Oral

Indications

No indication recorded.